Core Insights - Delivra Health Brands reported a 1% increase in net revenue for Q1 2026, reaching $3,207 thousand, driven by an 8% growth in Dream Water® sales and a 9% increase in LivRelief™ Non-Infused sales, despite a significant decline in licensed LivRelief™ Infused sales [5][6][10] - The company experienced a gross profit of $1,501 thousand with a gross profit margin of 47%, down from 51% in the same period last year, attributed to higher sales fees and changes in customer and product mix [5][6] - Adjusted EBITDA improved to $56 thousand from $16 thousand year-over-year, reflecting a $40 thousand increase due to higher sales volume and reduced sales and marketing expenses [10][8] Financial Performance - Net revenue for Q1 2026 was $3,207 thousand, compared to $3,163 thousand in Q1 2025, marking a $44 thousand increase [5][6] - Gross profit decreased to $1,501 thousand from $1,598 thousand, with a gross profit margin of 47% compared to 51% in the previous year [5][6] - Total expenses excluding non-cash items were $1,447 thousand, down 10% from $1,607 thousand in Q1 2025, primarily due to reduced sales and marketing expenses [10][7] Sales Growth - Dream Water® sales grew by 8% in the U.S. and Canada, while e-commerce sales for Dream Water® surged by 74% compared to the same quarter last year [5][6] - LivRelief™ experienced a 9% growth in sales, with e-commerce sales increasing by 16% [5][6] - The company anticipates a return to growth for the licensed LivRelief™ Infused segment in the second half of fiscal 2026 following a transition to a new distribution partner [2][5] Management Strategy - The management emphasized the importance of innovation, marketing, and channel diversification in driving recurring consumer demand [2] - Plans for new product launches with strategic customers are set for the second half of fiscal 2026 to enhance market coverage and customer base [2]

Core Points - Delivra Health Brands Inc. will report its annual financial results for the year ending June 30, 2025, on October 6, 2025 [1] - The company is positioned in the health and wellness sector, focusing on consumer packaged goods [1][4] - The conference call to discuss the financial results will take place on October 6, 2024, at 11:00 a.m. (EST) [2] Company Overview - Delivra Health offers alternative wellness solutions through brands like Dream Water® and LivRelief™, addressing issues such as chronic pain, anxiety, and sleeplessness [4] - The company aims to help customers reclaim their mobility, energy, and quality of life [4]

Core Viewpoint - Delivra Health Brands Inc. is expanding its Dream Water® brand by launching a new 6-Count Sleep Gummies product in the Gulf Cooperation Council (GCC) market, targeting key Middle Eastern markets through a partnership in Saudi Arabia, with availability expected by September 2025 [1][2]. Group 1: Product Launch and Market Expansion - The new 6-Count Sleep Gummies will be available in airports, major pharmacies, and e-commerce channels in the GCC region, which is identified as a high-growth market for wellness and sleep-support products [1]. - The launch represents a significant step in Delivra's global expansion strategy, enhancing brand presence and consumer convenience while increasing distribution opportunities [2]. Group 2: Company Strategy and Leadership - Gord Davey, President and CEO of Delivra Health, emphasized the strong demand for convenient, natural sleep solutions and the importance of partnering with international distributors who understand local markets [2]. - The product extension aims to provide a cost-effective entry point for both new and existing customers, reflecting the company's commitment to international growth [2]. Group 3: Stock Options Grant - On August 7, 2025, the Company’s Board of Directors approved the granting of 100,000 incentive stock options to certain directors, officers, and employees, exercisable at a price of $0.30 per common share, with a term of three years and immediate vesting [5].

Core Insights - Delivra Health Brands Inc. has expanded its presence in the U.S. by partnering with QVC, a major televised and online shopping network, to enhance distribution and consumer access [1][2] Group 1: Partnership Details - The partnership with QVC aims to leverage its extensive reach to millions of consumers, enhancing trial and awareness programs for Delivra Health's products [2] - QVC will feature a 16-pack of Dream Water Snoozeberry Sleep Shots, with the first airing on May 31, 2025, and availability for purchase on www.qvc.com thereafter [2] Group 2: Company Overview - Delivra Health focuses on providing alternative wellness solutions, with products designed to address issues like chronic pain, anxiety, and sleeplessness [3] - The company's portfolio includes innovative brands such as Dream Water® and LivRelief™, which have positively impacted millions of customers by improving their quality of life [3]

Core Insights - Delivra Health Brands Inc. is launching its new 60-Count Sleep Gummies in Middle Eastern markets through its Kuwait-based distributor, expected to be available by July 2025 [1][2] - The product expansion aims to leverage existing traction from Dream Water® Sleep Gummies in Canadian and U.S. markets, enhancing consumer choice in the Middle East [2] Company Strategy - The strategic partnership with local distributors is intended to unlock new growth opportunities by utilizing their regional market insights and proven performance [2] - The introduction of the 60-Count Sleep Gummies complements the existing Dream Water® liquid shots, reinforcing the brand's growth strategy in the health and wellness sector [2] Product Information - The 60-Count Sleep Gummies are part of Delivra Health's portfolio, which includes innovative brands like Dream Water® and LivRelief™, aimed at providing relief from issues such as chronic pain, anxiety, and sleeplessness [6]